Filing Details
- Accession Number:
- 0000930413-11-001216
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-24 18:32:09
- Reporting Period:
- 2011-02-22
- Filing Date:
- 2011-02-24
- Accepted Time:
- 2011-02-24 18:32:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 727510 | Enzon Pharmaceuticals Inc | ENZN | Biological Products, (No Disgnostic Substances) (2836) | 222372868 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1007931 | Robert Lebuhn | C/O Enzon Pharmaceuticals, Inc. 685 Route 202/206 Bridgewater, NJ 08807 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-02-22 | 10,000 | $10.88 | 96,519 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the weighted average price for sales of the shares. The shares were sold at prices ranging from $10.87 per share to $10.9001 per share.
- The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased or sold at each separate price.
Billionaire Hedge Funds
